Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 96Head and Neck Neoplasms 73Carcinoma, Non-Small-Cell Lung 34Thyroid Neoplasms 29Melanoma 26Ovarian Neoplasms 25Mouth Neoplasms 23Colorectal Neoplasms 20Oropharyngeal Neoplasms 19Breast Neoplasms 18Uterine Cervical Neoplasms 16Carcinoma, Squamous Cell 16Nasopharyngeal Carcinoma 15Lung Neoplasms 15Carcinoma, Renal Cell 15Neoplasm Metastasis 14Urinary Bladder Neoplasms 13Stomach Neoplasms 13Sarcoma 13Laryngeal Neoplasms 13Triple Negative Breast Neoplasms 12Prostatic Neoplasms 12Carcinoma 12Esophageal Neoplasms 11Endometrial Neoplasms 11Neoplasms 10Pancreatic Neoplasms 9Hypopharyngeal Neoplasms 9Salivary Gland Neoplasms 8Carcinoma, Transitional Cell 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Movement Disorders × Head & Neck × 30 days × Clear all
NCT07595666 2026-05-19

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

Universitaire Ziekenhuizen KU Leuven

Phase NA Enrolling by invitation
1,600 enrolled
CNSEndocrineHead & Neck

Amyotrophic Lateral Sclerosis, Brain Neoplasms, Dementia, Epilepsy, Head and Neck Neoplasms, Movement Disorders, Neuroblastoma, Parathyroid Neoplasms, Parkinson Disease, Pituitary Neoplasms, Lewy Body Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡